KLK3 and prostate carcinoma: When considering the clinical scenario previously mentioned, most ATHS providers would order a PSA test every 12 months (69%) and believed that, ideally, the patient's primary care provider should be responsible for his life-long prostate cancer surveillance (60%), though many providers also selected a urologist as the responsible individual (34%).